[Juvenile tumors].
D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000453:epidemiology*; D007680:Kidney Neoplasms / Q000473:pathology; D008197:Lymph Node Excision; D008297:Male; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000453:epidemiology*; D009373:Neoplasms, Germ Cell and Embryonal / Q000453:epidemiology; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D013724:Teratoma / Q000473:pathology; D013736:Testicular Neoplasms / Q000145:classification; D014565:Urogenital Neoplasms / Q000453:epidemiology; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000473:pathology
D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide
Tumoren im Kindesalter.